brivanib
Description: Brivanib is an investigational small-molecule kinase inhibitor studied as an anticancer drug targeting vascular and fibroblast growth factor signaling.
Primary topic: Hepatocellular Carcinoma Treatment and Prognosis (42%)
Wikidata ID: wiki/Q27075503
OpenAlex ID: keywords/brivanib
